Value of TAT and PIC with D‐dimer for Cancer Patients with Metastasis

Chanjuan Cui,Jia Gao,Jia Li,Mengyao Yu,Hao Zhang,Wei Cui
DOI: https://doi.org/10.1111/ijlh.13194
2020-01-01
International Journal of Laboratory Hematology
Abstract:Introduction The hypercoagulability of blood is related to the development and metastasis of cancer. High levels of D-dimer have been reported to be associated with the metastasis and poor prognoses of cancer. Here, we investigated the performance of biomarkers-TAT, PIC, TM, and tPAI center dot C by new method-for monitoring cancer patients with metastasis. Methods A total of 197 cancer patients were enrolled. TM, TAT, PIC, and tPAI center dot C were detected by the chemiluminescence immunoassay. Results Results showed that the levels of TAT and PIC were higher in the metastasis group than those in the nonmetastasis group (P < .01). In the nonmetastasis group, there were 16 patients with elevated levels of D-dimer. But, TAT and PIC in these 16 patients were all at normal level (<0.55 mg/L FEU). After dilution, D-dimer was also decreased to normal levels in these 16 patients. The ROC was used to show the performance of D-dimer, TAT, and PIC on indicating cancer with metastasis. The AUC of PIC was higher than that of D-dimer (0.825 vs. 0.770). The specificity and PPV of TAT and PIC were higher than those of D-dimer. Serial test of TAT, PIC, and D-dimer improved the specificity and positive predictive value to 90.91% [80.61%, 96.25%] and 89.29% [77.45%, 95.57%], respectively. Conclusion Combining TAT and PIC with D-dimer could be useful surveillance biomarkers for cancer with metastasis.
What problem does this paper attempt to address?